SYM Announced Its Strategic Transition

Today, SYM kicked off its strategic transition to a leading incubating business, with a new management team and an incubator focusing on neurosurgery and enhanced international cooperation. In doing so, SYM aims to meet the challenges brought by ever-evolving innovation and increasingly fierce competition in healthcare industry.

In addition, SYM remains committed to the principle of mutual trust and sharing, and the values of professionalism, specialization, and efficient cooperation.

Upholding the principles of “mutual trust and sharing”, SYM launched its open and mutual beneficial incubator – SYM-LAB – as a catalyst for the translation of medical discoveries and ideas into innovative products. As an accelerator for medical innovation, SYM-LAB aims to offer advantages and resources to innovative medical professionals to deliver more human-centred products and solutions.

SYM aims to transition towards an innovative R&D business specialized in neurosurgery. Working towards this goal, SYM has obtained multiple patents and certifications. In particular, the ground-breaking breaking Disposable Balloon Catheter Set for Cerebral Surgery (Cerebral Corridor Creator Set) was the first of its kind to provide new solution to establish operation channels in surgery. As the latest success story of SYM-LAB, the product leveraged SYM’s experience in developing and manufacturing high polymeric material.

SYM products are currently available in nearly 40 countries around the globe. In addition, SYM provides related training for international professionals, disseminating knowledge and expertise from China to improve patients’ well-being globally. Going forward, SYM will increase its cooperation with international partners against the background of China’s Belt & Road Initiative to promote technical exchange and boost international collaboration.